Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Nucl Cardiol. 2007 Apr;14(2):207–214. doi: 10.1016/j.nuclcard.2006.12.328

Figure 4.

Figure 4

A representative ex-vivo radionuclide image at the papillary muscle short-axis level after injection with 123I-MIBG, which illustrates that there is less uptake in the TMR-treated (LCx) region than in the untreated control (LAD) region.